Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial

Published:2023-03 Issue:10379 Volume:401 Page:843-855
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Keech Cheryl,Miller Vicki E,Rizzardi Barbara,Hoyle Christopher,Pryor Melinda J,Ferrand Jonathan,Solovay Ken,Thalen Marcel,Noviello Stephanie,Goldstein Peter,Gorringe Andrew,Cavell Breeze,He Qiushui,Barkoff Alex-Mikael,Rubin Keith,Locht Camille

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Routine vaccination coverage—worldwide 2021;Rachlin;MMWR Morb Mortal Wkly Rep,2022

2. An update of the global burden of pertussis in children younger than 5 years: a modelling study;Yeung;Lancet Infect Dis,2017

3. Pertussis—not just for kids;Hewlett;N Engl J Med,2005

4. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries;Kretzschmar;PLoS Med,2010

5. Toward a controlled human infection model of pertussis;Merkel;Clin Infect Dis,2020

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pertussis vaccination in adults in France: Overview and suggestions for improvement;Infectious Diseases Now;2024-09

2. Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges;ACS Nano;2024-08-26

3. Reemergencia de la tosferina: estrategias y retos en su control en España;Anales de Pediatría;2024-08

4. Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions;Expert Review of Vaccines;2024-07-24

5. Pertussis vaccines, epidemiology and evolution;Nature Reviews Microbiology;2024-06-21